Research examines the minimal risk standard for pediatric research

Arlene D Luu1

  • 1California Western School of Law, USA.

Insights

The "minimal" risk standard for pediatric research subjects is often inadequate. A new standard is needed for better assessment of research involving children.

Area of Science:

  • Pediatric Research Ethics
  • Clinical Trial Oversight
  • Regulatory Science

Background:

  • The "minimal" risk standard is the current benchmark for protecting pediatric research subjects.
  • This standard faces challenges due to ambiguous definitions and inconsistent application by Institutional Review Boards (IRBs).
  • These issues can compromise the adequate protection of children participating in research.

Purpose of the Study:

  • To identify the shortcomings of the "minimal" risk standard in pediatric research.
  • To advocate for an alternative ethical standard for assessing research involving pediatric subjects.
  • To propose a framework that enhances the protection of children in research settings.

Main Methods:

  • Systematic literature review of ethical guidelines and regulations for pediatric research.
  • Analysis of case studies involving IRB application of the "minimal" risk standard.
  • Comparative analysis of existing ethical frameworks for research subject protection.

Main Results:

  • The "minimal" risk standard's definitions are often unclear and inconsistently applied.
  • IRB practices vary significantly, leading to uneven protection for pediatric research participants.
  • Current standards may not sufficiently address the unique vulnerabilities of pediatric populations.

Conclusions:

  • The "minimal" risk standard is insufficient for safeguarding pediatric research subjects.
  • An alternative, more robust ethical standard is required for pediatric research assessment.
  • Implementing a revised standard will improve the ethical oversight and protection of children in clinical research.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...